Immunotherapy or other anti-cancer treatments and risk of exacerbation and mortality in cancer patients with COVID-19: a systematic review and meta-analysis [0.03%]
免疫治疗或其他抗肿瘤疗法在COVID-19癌症患者病情恶化和死亡风险中的作用：系统评价和meta分析
Bolin Wang,Yan Huang
Bolin Wang
Background: This study was designed to investigate whether COVID-19 patients with recently received immunotherapy or other anti-cancer treatments had more severe symptoms and higher mortality. ...
Meta-Analysis
Oncoimmunology. 2020 Sep 22;9(1):1824646. DOI:10.1080/2162402X.2020.1824646 2020
Significantly different immunological score in lung adenocarcinoma and squamous cell carcinoma and a proposal for a new immune staging system [0.03%]
肺腺癌和鳞状细胞癌免疫学评分显著不同及新免疫分期系统建议
Ziqing Zeng,Fan Yang,Yunliang Wang et al.
Ziqing Zeng et al.
TNM stage is not enough to accurately predict the prognosis of patients with non-small cell lung cancer (NSCLC). This study aimed to establish the immunological score (IS) in lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC...